Table 2 Comparison of baseline characteristics between patients with and without T2DM
Variables | T2DM | No T2DM | P value |
|---|---|---|---|
n | 1617 | 658 | Â |
Age ≥ 65 years | 1029 (64) | 371 (56) | 0.001 |
Male | 1168 (72) | 496 (75) | 0.13 |
Current smoker | 181 (11) | 108 (16) | 0.001 |
Hypertension | 1557 (96) | 440 (67) | < 0.001 |
BMI, kg/m2 | 26.0 ± 3.6 | 25.2 ± 3.6 | < 0.001 |
Systolic blood pressure, mmHg | 140 ± 21 | 131 ± 18 | < 0.001 |
Diastolic blood pressure, mmHg | 73 ± 11 | 74 ± 11 | 0.066 |
Triglycerides, mmol/L | 1.50 ± 1.02 | 1.46 ± 1.02 | 0.37 |
Total cholesterol, mmol/L | 3.80 ± 0.85 | 4.09 ± 0.97 | < 0.001 |
HDL-cholesterol, mmol/L | 1.16 ± 0.33 | 1.23 ± 0.34 | < 0.001 |
LDL-cholesterol, mmol/L | 1.95 ± 0.67 | 2.17 ± 0.84 | < 0.001 |
HbA1c, % | 7.38 ± 1.36 | 6.34 ± 1.17 | < 0.001 |
Ln-hs-Tnl, pg/mL | 2.2 ± 1.1 | 2.1 ± 1.4 | 0.44 |
Above cut-off (> 14.2 pg/mL) | 376 (23) | 135 (21) | 0.16 |
Ln-BNP, pg/mL | 3.8 ± 1.1 | 3.6 ± 1.2 | < 0.001 |
Above cut-off (> 56.7 pg/mL) | 672 (42) | 205 (31) | <0.001 |
Ln-enrollment period, month | 3.1 ± 0.8 | 2.9 ± 1.3 | <0.001 |
Outcomes | |||
 Major adverse cardiovascular events | 328 (20) | 74 (11) | < 0.001 |